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A  B  S  T  R  A  C  T   
 
The  desideratum aim  of the  present context was  to assess  the  biopotency of methanolic extracts of Eichhornia 
crassipes (E. crassipes), Pistacia vera (P. vera), and  Ziziphus amole (Z. amole) leaves  against various staphylococcal 
strains, and  to quantify the  phenolics as well  as saponin content in them. The  antibacterial activity of various 
concentrations (62.5–1000 μg/mL) of plant extracts was  tested against control clinical strains (Staphylococcus 
aureus  ATCC 25923, S. aureus  ATCC 29213, and  S. aureus  ATCC 43300), methicillin-resistant S. aureus  (MRSA1 
and MRSA2), oxacillin sensitive S. aureus (SOSA1 and SOSA2), and coagulase-negative Staphylococcus epidermidis 
(CoNS1,  CoNS2, and  CoNS3) using  disc  diffusion assay.  Leaf extracts of the  three plants exhibited pronounced 
growth inhibitory characteristics against staphylococci in a dose dependent manner. E. crassipes extract depicted 
the  highest relative percentage inhibition values  against control clinical strains (68.6  ± 0.5%), while  P. vera 
(68.6  ± 0.3%)  and  Z. amole (74.79 ± 0.3%)  extracts showed pronounced relative inhibition values  against 
staphylococcal strains isolated from  cattle. Total  phenols and  saponin content of leaf extracts were  investigated 
by standard in vitro methods. The methanolic extracts of these  plants were  found  to comprise substantial content 
of  phenolics and  saponin at  varying levels.  The  highest value  of  phenolics was  estimated in  P.  vera  extract 
(60.0  ± 1.3  mg  gallic  acid/g extract), followed by  Z. amole  (33.6  ± 1.4  mg  gallic  acid/g extract), and  E. 
crassipes (23.0 ± 1.3  mg gallic  acid/g extract). Saponin content for P. vera, Z. amole, and  E. crassipes extracts 
were  estimated as 41.0  ± 1.3, 35.8  ± 1.3, and 25.0  ± 1.2 mg diosgenin/g extract, respectively. The outcome 
of this study  suggested the exploitation of methanolic extract of P. vera, Z. amole, and  E. crassipes leaves  for their 
possible application in  ethnomedicine, particularly as drugs  preparation  against staphylococcal infections. In 
conclusion, the  study  indicates the  biopotency of these  plants against pathogenic MRSA present in cattle, and 




1.  Introduction 
 
The emergence and  development of drug  resistant bacterial patho- 
gens have substantially threatened the existing  antibacterial therapy. In 
general, bacteria have  the  genetic  potentiality to transmit and  acquire 
resistance to therapeutic drugs,  and  thus,  incidences of epidemics due 
to  drug  resistant bacteria are  now  a common  global  problem posing 
enormous public  health concerns  [1]. 
Staphylococcus sp. is one of the commensal bacteria that  constitute a 
major component of the normal skin and mucosal  microflora of humans 
[2].  In recent  years,  these  bacteria have  emerged as an  opportunistic 
pathogen, causing   bacteremia as  well  as  nosocomial infections [3]. 
Some Staphylococcus sp. are involved  in the pathogenesis of respiratory 
and  skin  infections [4],  and  also  form  biofilm  on  the  surfaces  of the 
medical   devices.   Staphylococci  strains   have   acquired resistance to 
several   other   antibiotics  and   most   antibiotic  resistance  genes   are 
plasmid-encoded  and   are   more   often   found   in  methicillin-resistant 
strains  [5]. 
The  high  cost  and  non-availability of  new  generation antibiotics 
have resulted in increase  in morbidity and mortality [1].  Consequently, 
this has led to the search  for more effective agents  of plant  origin,  with 
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template for the  synthesis  of new antibacterial drugs  [1]. 
Medicinal   plants  have  been  known  to  exhibit  myriad   benefits to 
mankind from ancient periods  due  to their  ample  pharmacological  as- 
pect.  Traditional applications of the  medicinal plants  have  fewer  side 
effects  that  lead  the  development of varied  phytomedicines globally 
[6].  Medicinal  plants  derived  secondary metabolites are vital sources  of 
distinct  phytochemicals that  could be used for the production of 
pharmaceutical products. At present, approximately 80% of the world's 
populace still  relies  on  the  plants  associated traditional  medicine for 
health care  needs.  Therefore, in the  current scenario, the  demand for 
herbal  medicines has surged  in comparison to the  synthetic drugs. 
Eichhornia crassipes (Water  hyacinth), belonging to the family 
Pontideriaceae is one of the most productive aquatic perennial herbs on 
earth, and  it has been known  for its unique  medicinal importance. The 
phytoconstituents of this plant  have vast biological properties including 
antiviral, antifungal, antitumor, and  antibacterial  activities [7].   Ad- 
ditionally, its  secondary metabolites have  been  considered to  be  in- 
volved  in the  chemical defense  of plants  against  plant  pathogens [8]. 
Pistacia vera, a member of Anacardiaceae family,  is one of the most 
economically important aromatic plants  and  widely  distributed in the 
Mediterranean region as well as USA. P. vera plants  are remarkably rich 
in linoleic and linolenic acids, the fatty acids vital for human health [9]. 
In addition to this,  Pistacia sp. were  previously reported to depict  var- 
ious biological activities such  as anti-atherogenic, hypoglycemic, anti- 
oxidant, anti-inflammatory, antifungal, and  insecticidal [10–12]. 
Ziziphus sp. (Rhamnaceae) comprises about  40 species distributed in 
warm-temperate and  sub-tropical regions.  Ziziphus plants  possess 
bioactive components that  are traditionally used as for the treatment of 
various  diseases  such as digestive  disorders, urinary troubles, diabetes, 
skin  infections, diarrhea, fever,  bronchitis, liver  complaints, anaemia, 
etc. [13]. Antimicrobial activity  of some members of genus Ziziphus had 
already been  reported in the  previous literature [14,15]. 
Considering the vast potentiality of plants  as sources  for therapeutic 
drugs  with  reference to antibacterial agents  and  the  urgent demand of 
the  current scenario  for developing new anti-staphylococci drugs  from 
natural sources,  the  present in vitro systemic  study  was undertaken to 
investigate the bioactive potential of methanolic extract  of E. crassipes, 
P. vera,  and  Z. amole leaves  against  ten  different strains  of staphylo- 
cocci. 
 
2.  Materials and methods 
 
2.1.  Plants collection 
 
E. crassipes,  P.  vera,  and  Z. amole  were  collected in  the  State  of 
Guerrero, municipality of Acapulco  de Juárez (20  m above  sea  level) 
during  the  winter period  of 2016,  taking  care  that  they  did  not  show 
signs  of stress  such  as discoloration, chlorosis, and  leaf curling  senes- 
cence.   The  fresh  and   disease   free  plants   were   separated  from  the 
branches, sorted,  cleaned, and  air-dried at room  temperature for 8-10 
days. The leaves were cut from the petiole  and allowed  to dry further at 
room  temperature. After  drying,   the  leaves   were   ground   in  a  mill 
(Pulvex  model  2000,  mesh 20, Mexico City). The resulting fine powder 
was  stored   in  plastic  and  kraft  paper   bags  at  20  °C in  a  dark  and 
moisture-free place  until  required for extraction process. 
 
2.2.  Extract preparation 
 
The powdered leaves  (2 g) of each  plant  were  mixed  successively 
into  400  mL of  methanol, and  obtained using  an  ultrasound  device 
(Shanghai Xiwen  Biotech  Co.,  model  XW-650Y, China,  Shanghai) in 
30  min  cycles  concentrating in  a  rota  evaporator (BUCHI model  R- 
3000,  Brazil, São Paulo) at 40 °C until reaching a final volume of 20 mL. 
The biomass  was separated from the extract  by vacuum  filtration using 
filter  paper  and  vacuum  pump.  The  resulting extracts were  stored  in 
amber  flasks  at  room  temperature. At the  same  time,  5  mL of each 
 
 
Fig.  1. Different sources of staphylococci viz.  S. aureus (Control), methicillin-resistant  S. 
aureus (Cattle),  oxacillin  sensitive  S.  aureus (Rabbit),  and   coagulase-negative  S.  epi- 
dermidis  (Rabbit). 
 
sample  was  stored  at  4 °C in capped  tubes  for further in vitro experi- 
mental  analysis. 
 
2.3.  In vitro antibacterial  evaluation 
 
2.3.1.  Bacteria of interest 
The indicator bacteria used for the antibacterial test include 
Staphylococcus aureus  ATCC 25923, S. aureus  ATCC 29213, S. aureus 
ATCC 43300, methicillin-resistant S. aureus (MRSA1 and  MRSA2), ox- 
acillin  sensitive  S. aureus (SOSA1 and  SOSA2), and  coagulase-negative 
Staphylococcus epidermidis (CoNS1, CoNS2, and  CoNS3). Fig. 1 depicts 
the various  control  staphylococci strains,  as well as isolates  from cattle 
and rabbits. Excluding  control  bacteria (S. aureus), methicillin-resistant 
S. aureus strains  were  isolated from  cattle,  while,  oxacillin  sensitive  S. 
aureus and coagulase-negative S. epidermidis were isolated from rabbits. 
Control  strains  viz. ATCC 25923, ATCC 29213, and  ATCC 43300  were 
obtained from the Center for Research  and Advanced  Studies in Animal 
Health    (CIESA),  Autonomous  University    of   the   State   of   Mexico 
(UAEMex). Methicillin-resistant S. aureus was isolated from cattle  using 
selective  MRSA agar  medium. The plates  were  incubated at  35 °C for 
48  h  and  plates  were  examined for  Staphylococcus sp.  Isolates  were 
screened for methicillin resistance using  disc diffusion assay.  Oxacillin 
sensitive  and  coagulase-negative strains  were  isolated from  rabbits  on 
MRSA and  MRS (de  Man,  Rogosa  and  Sharpe)   medium respectively 
using  standard protocol. All bacterial cultures were  sub-cultured into 
Brain-heart infusion  (BHI) broth  (BIOXON, DF, Mexico)  medium for 
further experimental purpose. 
 
2.3.2.  Disc diffusion assay 
Each  bacterial inoculum was  prepared in  5 mL of BHI broth, ad- 
justed  to a 0.5  McFarland scale  (1 × 106  CFU/mL),  and  incubated at 
37  °C for  24  h in  a rotatory shaker.  After  the  required period  of in- 
cubation, bacterial cultures were  swabbed on  selective  agar  medium 
plates.  Subsequently, methanolic extracts (25  μL) of leaves  at the  con- 
centrations of 62.5, 125, 250, 500, and 1000 μg/mL were transferred to 
sterile  discs (6 mm) and allowed  to soak for 10-15  min. The discs were 
transferred  aseptically to  the  plates   seeded   with  the  respective  sta- 
phylococci pathogens with  the  help  of ethanol dipped  and  flamed  for- 
ceps,  and  incubated at  37  °C for 24  h.  After 24  h,  zone  of inhibition 
(mm)    formed    by   different   plant    extracts   against    the    indicator 





pathogenic bacteria were  measured. Oxacillin  (1μg/disc) was  used  as 
positive  control  and  the  experiments were  carried out in triplicate. 
 
 
2.3.3.  Determination of relative percentage inhibition 
The  relative percentage inhibition (RPI)  of the  leaf  extracts with 
respect  to positive  control  was calculated as described below. 
3.2.  Relative percentage inhibition (RPI) of extracts against staphylococci 
strains 
 
Fig. 2a  depicts  the  RPI values  for  E. crassipes against  control  sta- 
phylococcal strains  as well as Staphylococcus sp. isolated from cattle  and 
rabbit. The methanolic extract  of this  plant  was found  to be the  most 
active  against  control  strains  (RPI% - 68.6  ± 0.5),  followed  by cattle 
(RPI% - 64.6  ± 0.6) and  rabbits  (RPI% - 61.7  ± 0.3) strains.  On the 
Relative percentage inhibition = 
 IHD EXT   − IHD NC 100 other  hand,  P. vera revealed maximum RPI values against  cattle  isolates 
IHD PC − IHD NC (68.6   ± 0.3%),   followed   by  rabbits   (65.7    ± 0.5%)   and   control 
 
where,  IHD = Inhibition halo diameter; EXT = Extract; NC = Negative 
control;  PC = Positive  control. 
 
 
2.4.  Estimation of total phenolics and saponin content 
 
Total  phenolics content in  the  leaf  extracts of the  plant  was  esti- 
mated   according to  the  methods of  Singleton  et  al.  [16]   with  some 
modifications. The  reaction mixture contains 1 mL of solvent  extract 
(1 mg/mL), 2.5 mL of 10% Folin-Ciocalteu's reagent dissolved  in water, 
and  2.5 mL of 7.5% Na2CO3. The samples  were  incubated at 45 °C for 
15 min and the absorbance was read at 765 nm. Blank includes  ethanol, 
instead of extract  solution. The calibration curve  was  prepared using 
Gallic  acid  as  standard at  the  concentrations of 20–100  μg/mL.  The 
total   phenolics content  was  calculated  as  milligrams  of  gallic  acid 
equivalent per gram of dry weight  of extract  (mg gallic acid/g extract). 
The total  saponin content in the leaf extracts of plant  was estimated 
according to  the  method described by  Makkar  et  al.  [17]   based  on 
vanillin-sulphuric acid  colorimetric reaction with  slight  modifications. 
Approximately 50 μL of plant  extract  was added  with 250 μL of distilled 
water.  To this,  about  250 μL of vanillin  reagent (800  mg of vanillin  in 
10 mL of 99.5%  ethanol) as well as 2.5 mL of 72% sulphuric acid was 
added  and  it was  mixed  well.  The solution  was  incubated in a water 
bath  at 60 °C for 10 min. After that,  it was cooled  in ice cold water  and 
the  absorbance was  read  at  544  nm.  The  total  saponin content was 
calculated as diosgenin equivalents (mg diosgenin/g extract). 
 
 
2.5.  Statistical analyses 
 
All experiments were  carried out  in triplicate and  results  were  ex- 
pressed  as mean  ± SD. Statistical analyses  were performed in factorial 
design with three  factors (extract of tree species, extract  concentrations, 
and  bacterial strains)  using  the  GLM Procedure. 
 
 
3.  Results 
 
3.1.  In vitro antibacterial  assessment 
 
The  methanolic extracts of  plant   leaves  showed   broad-spectrum 
antibacterial activity   against   various   staphylococci strains   in  a  dose 
dependent manner. E. crassipes extract  showed  potent bactericidal ac- 
tivity     against     CoNS1    with     maximum   zone    of    inhibition    of 
14.63   ± 0.16  mm at 1000  μg/mL  of concentration. A minimum zone 
of inhibition of 10.17  ± 0.35 mm was observed against  ATCC 43300  at 
higher  concentration of E. crassipes extract. The methanolic extract  of P. 
vera was  found  to be the  most  active  against  ATCC 25923  with  max- 
imum  zone of inhibition of 14.63   ± 0.15  mm at 1000  μg/mL  of con- 
centration. The  extract  was  found  to  be  less  effective against  SOSA2 
with minimum zone of inhibition of 10.32  ± 0.28 mm. In like manner, 
Z. amole  exhibited potent  growth   inhibitory property against   ATCC 
25923   with   maximum  zone  of  14.76   ± 0.23  mm  at  higher   con- 
centration. In accordance to the bactericidal zone of plant  extracts, the 
relative percentage inhibition (i.e.,  RPI) values  were  found  to  be  af- 
fected  (Table  1). 
(59.9   ± 0.4%)  strains  (Fig.  2b).  Similar  to  P. vera extract, the  me- 
thanolic extract  of Z. amole showed  promising RPI values  against  sta- 
phylococcal strains  in the order  of 74.79   ± 0.3% (cattle) > 67.3  ± 
0.4% (rabbits) > 66.5  ± 0.5% (control) (Fig. 2c). 
 
3.3.  Quantification  of total phenolics and total saponins 
 
The present findings showed  that  the content of total  phenolics and 
total  saponins differed significantly among  the  methanolic extract  of 
plants.   P.  vera  extract   showed  substantial amount of  total  phenolics 
content with  the highest  value  of 60.0  ± 1.3 mg gallic acid/g extract, 
followed  by  Z. amole  (33.6   ± 1.4  mg  gallic  acid/g extract) and  E. 
crassipes (23.0   ± 1.3  mg  gallic  acid/g extract) (Fig.  3a).  The  total 
saponin content for Z. amole, E. crassipes, and  P. vera extracts were  es- 
timated as 35.8   ± 1.3,  25.0   ± 1.2  and  41.0   ± 1.3  mg  diosgenin 
(DE)/g  extract, respectively (Fig. 3b). 
 
4.  Discussion 
 
Humankind has  been  relied   on  the  traditional uses  of  plants   as 
therapeutics  from   ancient  periods.  Secondary metabolites  obtained 
from  the  plants   are  found  to  be  an  important source  of  diversified 
phytoconstituents that   could  be  used  for  the  production of  several 
pharmaceuticals. At present, in  the  developing as  well  as  developed 
countries, human populace still  rely  on  the  plants  derived  traditional 
medicine for health care needs.  Thus, the demand for herbal  medicines 
as potent therapeutic agents  is continuously increasing day  by day  in 
comparison to  the  synthetic drugs.  Staphylococcus sp.  is predominant 
among  the  microorganisms responsible for infective  complications  fol- 
lowing  surgical  vascular   grafts  or  the  implantation of prosthetic  de- 
vices. Staphylococcus sp. is the chief organism accountable for infections 
of  prosthetic  heart   valves,   artificial  joints,   urinary  tract,   and  cere- 
brospinal fluid  shunts. 
Researchers mainly  focus on the medicinal plants  rather than  on the 
common  weeds  which  are  also the  source  of many  phytochemicals. In 
the  present study,  E. crassipes was  tested  for  its  antibacterial activity 
against  staphylococci strains,  and  depicted pronounced inhibition on 
the growth  of Staphylococcus sp. tested.  Furthermore, the RPI value  for 
the  plant   extract   was  observed to  be  the  maximum against   control 
staphylococcal strains.  The cattle  and  rabbits  strains  were  found  to be 
less  susceptible to  the  extract. Similar  observation was  reported  by 
Shehnaz  and  Vijayalakshmi [18]  who  demonstrated the  bioactivity of 
methanolic extract  of E. crassipes flowers  against  Staphylococcus sp. In 
another report, Zhou et al. [19]  observed pH, concentration, and  time 
dependent antibacterial activity  of E. crassipes extract  against  Staphy- 
lococcus sp. 
Although   the  biological  activities  of  some  species   of  the  genus 
Pistacia has been investigated, studies  on the antibacterial properties of 
methanolic extract  of P. vera are  currently very  limited, probably not 
available. The  present context   evaluated the  strong  antibacterial  ac- 
tivity  of the  methanolic extract   of P. vera  against   few  staphylococci 
strains  in  a dose  dependent manner. Staphylococcus sp.  isolated from 
cattle,  in a comparison with control  and rabbit strains  were observed to 
be highly susceptible to the methanolic extract  of P. vera in terms of RPI 
determination. According to the report of Smeriglio et al. [20], essential 
oil of P. vera was found  to be markedly effective against  clinical  strains 






Antibacterial activity and  relative percentage inhibition of plant  extracts  against  Staphylococcus sp. 
 
Plants Strains Strains origin Extract activity   Oxacillin activity RPI (%)* 
   Concentrations IZ (mm)*  IZ (mm)  
   (μg/mL)     
E. crassipes ATCC 25923 Control 62.5 7.57 ± 0.15  14.50 ± 0.30 52.2 
   125 8.15 ± 0.27   56.2 
   250 9.25 ± 0.30   63.7 
   500 10.73 ± 0.52   74 
   1000 12.20 ± 0.25   84.1 
 ATCC 29213 Control 62.5 8.65 ± 0.14  14.63 ± 0.51 59.1 
   125 9.71 ± 0.25   66.3 
   250 10.32 ± 0.65   70.6 
   500 11.54 ± 0.50   78.9 
   1000 12.79 ± 0.26   87.4 
 ATCC 43300 Control 62.5 6.61 ± 0.25  12.37 ± 0.40 53.4 
   125 6.94 ± 0.15   56.1 
   250 8.53 ± 0.50   68.9 
   500 9.40 ± 0.30   75.9 
   1000 10.17 ± 0.35   82.2 
 MRSA1 Cattle 62.5 5.17 ± 0.38  12.43 ± 0.45 41.6 
   125 7.64 ± 0.41   61.4 
   250 8.20 ± 0.28   65.9 
   500 9.47 ± 0.16   76.1 
   1000 11.10 ± 0.26   89.3 
 MRSA2 Cattle 62.5 8.73 ± 0.25  18.53 ± 0.40 47.1 
   125 10.64 ± 0.15   57.4 
   250 11.57 ± 0.28   62.4 
   500 12.37 ± 0.24   66.8 
   1000 14.40 ± 0.33   77.8 
 SOSA1 Rabbits 62.5 8.10 ± 0.17  14.34 ± 0.30 56.4 
   125 8.18 ± 0.28   57.1 
   250 9.76 ± 0.21   68.1 
   500 10.60 ± 0.20   73.9 
   1000 11.33 ± 0.21   79 
 SOSA2 Rabbits 62.5 7.80 ± 0.20  18.10 ± 0.51 43 
   125 11.44 ± 0.21   63.2 
   250 12.37 ± 0.27   68.3 
   500 14.50 ± 0.21   80.1 
   1000 14.60 ± 0.25   80.6 
 CoNS1 Rabbits 62.5 6.99 ± 0.62  18.60 ± 0.23 37.6 
   125 8.79 ± 0.23   47.2 
   250 10.00 ± 0.26   53.8 
   500 11.23 ± 0.11   60.3 
   1000 14.63 ± 0.16   78.7 
 CoNS2 Rabbits 62.5 7.68 ± 0.28  14.25 ± 0.30 53.9 
   125 7.88 ± 0.10   55.2 
   250 9.63 ± 0.32   67.6 
   500 10.25 ± 0.51   71.9 
   1000 11.43 ± 0.16   80.2 
 CoNS3 Rabbits 62.5 7.92 ± 0.10  18.53 ± 0.50 42.8 
   125 9.21 ± 0.09   49.8 
   250 9.38 ± 0.13   50.7 
   500 10.43 ± 0.30   56.2 
   1000 12.30 ± 0.50   66.3 
(continued on next  page) 





Table 1 (continued) 
 
Plants Strains Strains origin Extract activity   Oxacillin activity RPI (%)* 
   Concentrations IZ (mm)*  IZ (mm)  
   (μg/mL)     
P. vera ATCC 25923 Control 62.5 9.13 ± 0.32  18.37 ± 0.40 49.8 
   125 10.30 ± 0.20   56.1 
   250 11.43 ± 0.25   62.2 
   500 12.40 ± 0.21   67.5 
   1000 14.63 ± 0.15   79.8 
 ATCC 29213 Control 62.5 6.30 ± 0.20  18.33 ± 0.42 34.3 
   125 8.65 ± 0.65   47.1 
   250 9.63 ± 0.10   52.6 
   500 10.33 ± 0.23   56.3 
   1000 14.51 ± 0.58   79.1 
 ATCC 43300 Control 62.5 4.85 ± 0.22  12.43 ± 0.17 39.1 
   125 5.33 ± 0.58   42.9 
   250 8.60 ± 0.42   69.1 
   500 9.76 ± 0.65   78.5 
   1000 10.37 ± 0.31   83.4 
 MRSA1 Cattle 62.5 5.43 ± 0.23  12.30 ± 0.32 44.1 
   125 6.58 ± 0.40   53.4 
   250 8.15 ± 0.12   66.2 
   500 9.33 ± 0.61   75.9 
   1000 11.33 ± 0.40   92.1 
 MRSA2 Cattle 62.5 6.20 ± 0.26  12.43 ± 0.23 49.9 
   125 7.98 ± 0.30   64.1 
   250 8.40 ± 0.13   67.6 
   500 10.00 ± 0.19   80.4 
   1000 11.50 ± 0.46   92.5 
 SOSA1 Rabbits 62.5 7.12 ± 0.16  14.24 ± 0.41 50 
   125 9.47 ± 0.25   66.5 
   250 10.45 ± 0.09   73.3 
   500 11.43 ± 0.26   80.2 
   1000 12.30 ± 0.76   86.3 
 SOSA2 Rabbits 62.5 6.13 ± 0.61  10.45 ± 0.35 58.7 
   125 6.66 ± 0.30   63.8 
   250 7.17 ± 0.15   68.7 
   500 9.28 ± 0.57   88.9 
   1000 10.32 ± 0.28   98.7 
 CoNS1 Rabbits 62.5 7.13 ± 0.65  14.60 ± 0.30 48.9 
   125 8.70 ± 0.20   59.6 
   250 9.28 ± 0.82   63.6 
   500 11.00 ± 0.25   75.3 
   1000 12.30 ± 0.17   84.2 
 CoNS2 Rabbit 62.5 6.67 ± 0.21  12.65 ± 0.51 52.8 
   125 7.40 ± 0.40   58.4 
   250 7.83 ± 0.50   61.9 
   500 9.56 ± 0.60   75.6 
   1000 10.78 ± 0.67   85.2 
 CoNS3 Rabbits 62.5 6.32 ± 0.13  18.60 ± 0.36 33.9 
   125 7.23 ± 0.61   38.9 
   250 9.43 ± 0.60   50.7 
   500 10.42 ± 0.26   56.1 
   1000 11.56 ± 0.30   62.1 
(continued on next  page) 





Table 1 (continued) 
 
Plants Strains Strains origin Extract activity   Oxacillin activity RPI (%)* 
   Concentrations IZ (mm)*  IZ (mm)  
   (μg/mL)     
Z. amole ATCC 25923 Control 62.5 9.80 ± 0.20  14.78 ± 0.51 66.6 
   125 10.48 ± 0.09   71.1 
   250 11.32 ± 0.30   76.9 
   500 12.65 ± 0.15   85.9 
   1000 14.76 ± 0.23   99.8 
 ATCC 29213 Control 62.5 5.85 ± 0.12  14.32 ± 0.60 40.9 
   125 6.33 ± 0.21   44.2 
   250 7.44 ± 0.21   51.9 
   500 10.12 ± 0.16   70.7 
   1000 12.45 ± 0.13   86.9 
 ATCC 43300 Control 62.5 8.79 ± 0.20  18.10 ± 0.45 48.6 
   125 9.30 ± 0.11   51.3 
   250 10.15 ± 0.27   56 
   500 12.32 ± 0.14   68 
   1000 14.16 ± 0.34   78.2 
 MRSA1 Cattle 62.5 8.42 ± 0.45  12.60 ± 0.53 66.9 
   125 9.30 ± 0.22   73.8 
   250 9.48 ± 0.30   75.2 
   500 10.47 ± 0.21   83 
   1000 11.58 ± 0.34   91.9 
 MRSA2 Cattle 62.5 6.33 ± 0.14  12.32 ± 0.37 51.3 
   125 8.22 ± 0.17   66.8 
   250 8.56 ± 0.23   69.4 
   500 9.30 ± 0.14   75.4 
   1000 11.61 ± 0.18   94.2 
 SOSA1 Rabbit 62.5 7.19 ± 0.20  18.42 ± 0.52 39 
   125 9.06 ± 0.16   49.1 
   250 10.13 ± 0.21   54.9 
   500 12.44 ± 0.24   67.5 
   1000 14.30 ± 0.14   77.6 
 SOSA2 Rabbits 62.5 8.52 ± 0.24  14.62 ± 0.47 58.2 
   125 9.40 ± 0.16   64.2 
   250 10.39 ± 0.51   71 
   500 11.52 ± 0.27   78.8 
   1000 12.83 ± 0.31   87.8 
 CoNS1 Rabbits 62.5 8.23 ± 0.32  14.63 ± 0.15 56.2 
   125 9.76 ± 0.35   66.8 
   250 10.15 ± 0.24   69.3 
   500 12.35 ± 0.11   84.4 
   1000 12.75 ± 0.15   87.1 
 CoNS2 Rabbits 62.5 7.85 ± 0.23  14.16 ± 0.16 55.4 
   125 8.28 ± 0.43   58.4 
   250 9.75 ± 0.34   68.9 
   500 10.25 ± 0.24   72.3 
   1000 12.32 ± 0.15   87 
 CoNS3 Rabbits 62.5 10.09 ± 0.14  18.53 ± 0.31 54.4 
   125 11.59 ± 0.13   62.6 
   250 12.15 ± 0.16   65.6 
   500 12.92 ± 0.32   69.8 
   1000 14.10 ± 0.18   76 
RPI,  Relative Percentage Inhibition.       
IZ, Inhibition Zone. 
 
of staphylococci. In another study,  P. vera polyphenols were  shown  to 
exhibit  bactericidal property against  MRSA strains  [21]. As previously 
stated  by other  authors, the activity  may be due to the cell wall or cell 
membrane disruption together with  cell enlargement [22]. 
Ziziphus sp. is reported to possess bioactive constituents, recognized 
for traditional use and therapeutic importance. Present  work evaluated 
the  antibacterial potentiality of  Z. amole  methanolic extract   against 
pathogenic strains  of staphylococci. Interestingly, the RPI value  for the 
extract   was  found  to  be  the  highest   against   strains  of  cattle   origin, 
followed  by rabbits  and  control  staphylococcal strains.  Antimicrobial 
activity  of some  other  species  of genus  Ziziphus has  already been  re- 
ported in the  previous literature [23,24]. In another report, Z. maur- 
itiana methanol extract  showed  promising antibacterial activity  against 
S. aureus  [25]. The variation in activities observed amongst different 
species  might  be  due  to  the  diversity of bioactive compounds under 
influence of genetic  features and  environmental aspects  [26]. 
The phenolics are  the  largest  known  groups  of secondary metabo- 
lites   exhibiting  antibacterial  activities.  The  number  of  site(s)   and 
phenol  hydroxyl  groups  leads  to the  increased hydroxylation, causing 
relative toxicity  to  bacteria [27]. The  results  of  the  present context 
revealed that  the  total  phenolics content differed significantly among 
the  plant   extracts.  The  total   phenolics content  of  the  extracts  was 
compared with the standard Gallic acid and the values were found to be 
maximum for P. vera extract, followed  by Z. amole and  E. crassipes ex- 
tract.  Our  findings were  found  to be in complete agreement with  the 
reports of Shanab  and Shalaby  [28]  who observed the substantial level 
of  phenolics content  in  the  methanolic extract   of  E.  crassipes.  Pre- 
viously,       phenolic     components     viz.      4-methylresorcinol,      2- 







Fig.   2. Susceptibility (RPI  %)  of  control S.  aureus strains 
and  other staphylococci from  cattle and  rabbits to  the  me- 































































methylresorcinol, catechol, pyrogallol, genetisic, p-hydroxybenzoic, 
salicylic acids, and resorcinol have been reported in the various  parts of 
E. crassipes [29]. 
Saponin  has been reported to have a wide range  of pharmacological 
and  medicinal activities. The  present study  revealed the  significant 
level of saponin content in the  methanolic extract  of P. vera, Z. amole, 
and  E. crassipes. Interestingly, saponin has  been  reported to  have  ne- 
maticidal, molluscicidal, insecticidal and  antioxidant properties [30]; 







Fig.  3. Total phenolics (a)  and  total saponins (b)  measured from  the  methanolic extracts. 
 
tumoricidal activity  [31], and  antimicrobial characteristics [32]. The 
significant level  of saponin in  the  leaves  might  be  as  a result  of the 
necessity  to  protect plants  against  pathogens. It has  been  noted  that 
many  saponins are  present in  healthy plants   in  high  concentrations 
because   of  their   antimicrobial  properties.  The  presence  of  saponin 
might   be  to  serve  as  a  natural defense   mechanism. Plants  need  to 
protect themselves against  herbivores and  pathogens [33]. The poten- 
tial anti-staphylococcal characteristics of plants  studied in this in- 
vestigation might  be due to the efficacy  of vast secondary metabolites, 
including phenolic compounds and  saponins [34,35].  Based  on  the 
outcome of this  investigation, the  use of P. vera, Z. amole, and  E. cras- 
sipes leaves  in  ethnomedicine as  therapeutic drugs  against   staphylo- 
coccal  infections is thus  suggested. 
 
5.  Conclusions 
 
In a nutshell, the present study  demonstrated the potentiality of the 
methanolic extract  of P. vera, Z. amole, and E. crassipes leaves to inhibit 
the  growth  of various  staphylococci strains.  Additionally, cattle  were 
found   to  be  the  host  for  diversiform pathogenic  strains   of  MRSA. 
Rabbits  were  observed as host  for SOSA and  CoNS strains,  which  in- 
dicates   alarming situation for  the  livestock  industries. Tested  plants 
exhibited pronounced activity  against  all the  indicator Staphylococcus 
sp. in a dose dependent manner. E. crassipes extract  revealed promising 
RPI values against  control  strains,  followed  by staphylococcal strains  of 
cattle  and  rabbits. In  contrary to  this,  P. vera  and  Z. amole  extracts 
showed   high  RPI  values  against   staphylococci isolated  from  cattle, 
followed  by rabbits  and  control  strains.  Further, the  findings revealed 
the  presence of two  important groups  of phytoconstituents viz.  phe- 
nolics and  saponin in the  methanolic extract  of the investigated plants 
in a substantial amount. This study  suggests  that  these  plants  can  be 
productively used  in the  pharmaceutics, particularly against  staphylo- 
coccal  infections because  of its promising activities as well as the  pre- 
sence  of bioactive phytoconstituents reported. 
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